Evidence map›Paper›PMID 37184617›Full record

SynthesisDigestive diseases and sciences2023

Etiologies and Outcomes of Transaminase Elevation > 1000 IU/L: A Systematic Review and Meta-Analysis.

Mouhand F Mohamed, Neha Wadhavkar, Yousef Elfanagely, Daniel Marino, Azizullah Beran, Mohamed Abdallah, Kittichai Promrat

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Digestive diseases and sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Frequencies of anInternational journal of molecular sciences · 2024
    Article
  5. Viral hepatitis-induced acute liver failure.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mouhand F Mohamed *Division of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, USA. mouhand@brown.edu.ORCID 0000-0002-4761-8014
Neha Wadhavkar *Division of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Yousef ElfanagelyDivision of Gastroenterology, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Daniel MarinoDivision of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Azizullah BeranGastroenterology and Hepatology Department, Indiana University, Indianapolis, IN, USA.
Mohamed AbdallahDivision of Gastroenterology, University of Minnesota, Minneapolis, MN, USA.
Kittichai PromratDivision of Gastroenterology, The Warren Alpert Medical School of Brown University, Providence, RI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmong liver injury causes, few result in marked elevation of liver enzymes to a level > 1,000 international units per liter (IU/L). This review summarizes common etiologies of marked transaminase elevation and associated prognostic factors.

methodsWe performed a comprehensive search on PubMed, EMBASE, Cochrane Library, and Google Scholar from inception through December 2022 using MOOSE guidelines for studies reporting frequency of etiologies of marked transaminase elevation. We used a proportion meta-analysis to pool frequencies with corresponding 95% confidence interval (CI). I

resultsSeven relevant studies (n = 1608 patients) were included. The pooled frequency of ischemic hepatitis was 51% (95% CI 42-60%, I DISCUSSION: This is the first meta-analysis to examine etiologies of marked transaminase elevation > 1000 IU/L. Liver ischemia is the most common cause, while other causes include DILI or toxins, viral hepatitis, and biliary pathologies. We found biliary pathologies to be the fourth most common cause. This is clinically relevant as it has been traditionally linked to a cholestatic pattern of liver injury. Being aware of this presentation may help prevent delayed or missed diagnoses and unnecessary testing.

Indexed as

Chemical and Drug Induced Liver InjuryCholestasisHepatitis, Viral, HumanLiver DiseasesAlanine TransaminaseAspartate AminotransferasesHumansAlanine TransaminaseAspartate AminotransferasesALTAminotransferaseASTExtreme transaminase elevationSevere liver injury

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.